{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 376116641
| IUPAC_name = 1-isopropyl-7-methyl-4-phenylquinazolin-2(1''H'')-one
| image = proquazone.png

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =  

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  

<!--Identifiers-->
| CAS_number_Ref = {{cascite|changed|??}}
| CAS_number = 22760-18-5 
| ATC_prefix = M01
| ATC_suffix = AX13
| PubChem = 31508
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| UNII_Ref = {{fdacite|changed|FDA}}
| UNII = 42VPJ2980S
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 268501
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID      = 29222

<!--Chemical data-->
| C=18 | H=18 | N=2 | O=1 
| molecular_weight = 278.34832 g/mol
| smiles            = CC1=CC2=C(C=C1)C(=NC(=O)N2C(C)C)C3=CC=CC=C3
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI          = 1S/C18H18N2O/c1-12(2)20-16-11-13(3)9-10-15(16)17(19-18(20)21)14-7-5-4-6-8-14/h4-12H,1-3H3
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey       = JTIGKVIOEQASGT-UHFFFAOYSA-N
}}

'''Proquazone''' is a [[nonsteroidal anti-inflammatory drug]].<ref>{{Cite journal 
| doi = 10.2165/00003495-198733050-00004 
| last1 = Clissold | first1 = S. P. 
| last2 = Beresford | first2 = R. 
| title = Proquazone. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in rheumatic diseases and pain states 
| journal = Drugs 
| volume = 33 
| issue = 5 
| pages = 478–502 
| year = 1987 
| pmid = 3297621
}}</ref>

==Synthesis==
<ref name="CoombsDanna1973">{{cite journal|last1=Coombs|first1=R. V.|last2=Danna|first2=R. P.|last3=Denzer|first3=M.|last4=Hardtmann|first4=G. E.|last5=Huegi|first5=B.|last6=Koletar|first6=G.|last7=Koletar|first7=J.|last8=Ott|first8=H.|last9=Jukniewicz|first9=E.|title=Synthesis and antiinflammatory activity of 1-alkyl-4-aryl-2(1H)-quinazolines and quinazolinethiones|journal=Journal of Medicinal Chemistry|volume=16|issue=11|year=1973|pages=1237–1245|issn=0022-2623|doi=10.1021/jm00269a006}}</ref>
<ref>G. Gamboni, W. Schmid and A. Sutter; GB1592687 (1981 to Sandoz).</ref>

==References==
{{Reflist}}

{{Anti-inflammatory and antirheumatic products}}

[[Category:Quinazolinones]]
[[Category:Ureas]]


{{musculoskeletal-drug-stub}}